Can they go to human cancer trials with the newly formulated tablet or would they need to use the liquid filled tablets previously used in the Adelaide Hospital trail?
If the need phase 1 safety data from the new tablets ie from the current MND trial what is the point banging on about the path travel, this is where we are now, much more advanced although it has taken some time getting to this point, we have taken a few detours but the goal has been the same, things don’t alway go as planned.
Can they go to human cancer trials with the newly formulated...
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.3¢ |
Change
-0.008(4.17%) |
Mkt cap ! $83.90M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.3¢ | $59.77K | 338.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 376984 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 25091 | 2 |
View Market Depth
| Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |